General Information of Binding Target of SBP (BTS) (ID: ST00016)
BTS Name
CD276 antigen
Synonyms
4Ig-B7-H3; B7 homolog 3; B7-H3; Costimulatory molecule; CD antigen CD276
BTS Type
Protein
Family
Immunoglobulin superfamily;
BTN/MOG family
Gene Name
CD276
Organism
Homo sapiens (Human)
Function
May participate in the regulation of T-cell-mediated immune response. May play a protective role in tumor cells by inhibiting natural-killer mediated cell lysis as well as a role of marker for detection of neuroblastoma cells. May be involved in the development of acute and chronic transplant rejection and in the regulation of lymphocytic activity at mucosal surfaces. Could also play a key role in providing the placenta and fetus with a suitable immunological environment throughout pregnancy. Both isoform 1 and isoform 2 appear to be redundant in their ability to modulate CD4 T-cell responses. Isoform 2 is shown to enhance the induction of cytotoxic T-cells and selectively stimulates interferon gamma production in the presence of T-cell receptor signaling.
UniProt ID
Q5ZPR3
UniProt Entry
CD276_HUMAN
PFam
PF07686
Gene ID
80381
Sequence
MLRRRGSPGMGVHVGAALGALWFCLTGALEVQVPEDPVVALVGTDATLCCSFSPEPGFSL
AQLNLIWQLTDTKQLVHSFAEGQDQGSAYANRTALFPDLLAQGNASLRLQRVRVADEGSF
TCFVSIRDFGSAAVSLQVAAPYSKPSMTLEPNKDLRPGDTVTITCSSYQGYPEAEVFWQD
GQGVPLTGNVTTSQMANEQGLFDVHSILRVVLGANGTYSCLVRNPVLQQDAHSSVTITPQ
RSPTGAVEVQVPEDPVVALVGTDATLRCSFSPEPGFSLAQLNLIWQLTDTKQLVHSFTEG
RDQGSAYANRTALFPDLLAQGNASLRLQRVRVADEGSFTCFVSIRDFGSAAVSLQVAAPY
SKPSMTLEPNKDLRPGDTVTITCSSYRGYPEAEVFWQDGQGVPLTGNVTTSQMANEQGLF
DVHSVLRVVLGANGTYSCLVRNPVLQQDAHGSVTITGQPMTFPPEALWVTVGLSVCLIAL
LVALAFVCWRKIKQSCEEENAGAEDQDGEGEGSKTALQPLKHSDSKEDDGQEIA
Sequence Length
534
Synthetic Binding Protein (SBP) Targeting This BTS
SBP Name Highest Status Mechanism Affinity Application Details Ref
Affibody anti-CD276 AC12 Research Binder Kd: 0.9 nM Tumors [ICD-11: XH1N44]
SBP Info
[1]
Affibody anti-CD276 AC16 Research Binder Kd: 20 nM Tumors [ICD-11: XH1N44]
SBP Info
[1]
Affibody anti-CD276 AC9 Research Binder Kd: 18 nM Tumors [ICD-11: XH1N44]
SBP Info
[1]
DART Obrindatamab Phase I; Discontinued Binder N.A. B7-H3-positive tumors
SBP Info
[2]
References
1 Cellular-Based Selections Aid Yeast-Display Discovery of Genuine Cell-Binding Ligands: Targeting Oncology Vascular Biomarker CD276. ACS Comb Sci. 2019 Mar 11;21(3):207-222.
2 MacroGenics. Data from MacroGenics' Preclinical Studies of MGD009 Presented at Keystone Symposia's Antibodies as Drugs (X2) Conference. Mar 7 2016.